Kroon, Bin K <br/><br/>
Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation.  [electronic resource] 

 -  Urology  Jan 2013 
 - 111-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/j.urology.2012.09.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Renal Cell--drug therapy<br/>Humans<br/>Indoles--therapeutic use<br/>Kidney Neoplasms--drug therapy<br/>Neoadjuvant Therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Probability<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrroles--therapeutic use<br/>Sorafenib<br/>Sunitinib<br/>Tumor Burden--drug effects